Références bibliographiques

1. Amador, X. F., Strauss, D. H., Yale, S. A., Flaum, M. M., Endicott, J., & Gorman, J. M. (1993). Assessment of insight in psychosis. American Journal of Psychiatry, 150(6), 873-879.
2. Ascher-Svanum, H., Faries, D. E., Zhu, B., Ernst, F. R., Swartz, M. S., & Swanson, J. W. (2006). Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry, 67(3), 453-460.
3. Baddeley, A. (2003). Working memory: looking back and looking forward. Nat Rev Neurosci, 4(10), 829-839.
4. Baddeley, A. (2010). Working memory. Curr Biol, 20(4), R136-140.
5. Baddeley, A., & Hitch, G. J. (1974). Working Memory (Bower, G.A. ed. Vol. 8). New York City: Academic Press.
6. Beebe, L. H. (2010). What community living problems do persons with schizophrenia report during periods of stability? Perspect Psychiatr Care, 46(1), 48-55.
7. Bowie, C. R., & Harvey, P. D. (2005). Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatric Clinics of North America, 28(3), 613-633.
8. Bustini, M., Stratta, P., Daneluzzo, E., Pollice, R., Prosperini, P., & Rossi, A. (1999). Tower of Hanoi and WCST performance in schizophrenia: problem-solving capacity and clinical correlates. J Psychiatr Res, 33(3), 285-290.
9. Byerly, M., Fisher, R., Whatley, K., Holland, R., Varghese, F., Carmody, T., et al. (2005). A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res, 133(2-3), 129-133.
10. Byerly, M. J., Nakonezny, P. A., & Rush, A. J. (2008). The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 100(1-3), 60-69.
11. Byerly, M. J., Thompson, A., Carmody, T., Bugno, R., Erwin, T., Kashner, M., et al. (2007). Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr Serv, 58(6), 844-847.
12. Caron, J., Mercier, C., & Tempier, R. (1997). [Validation of Satisfaction with Life Domains Scale in Quebec]. Sante Ment Que, 22(2), 195-217.
13. Carpenter, P. A., Just, M. A., & Reichle, E. D. (2000). Working memory and executive function: evidence from neuroimaging. Curr Opin Neurobiol, 10(2), 195-199.
14. Caspi, A., Reichenberg, A., Weiser, M., Rabinowitz, J., Kaplan, Z., Knobler, H., et al. (2003). Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophrenia Research, 65(2-3), 87-94.
15. Chambon, V., Franck, N., Koechlin, E., Fakra, E., Ciuperca, G., Azorin, J. M., et al. (2008). The architecture of cognitive control in schizophrenia. Brain, 131(4), 962-970.
16. Chan, R. C., Chen, E. Y., Cheung, E. F., & Cheung, H. K. (2004). Executive dysfunctions in schizophrenia. Relationships to clinical manifestation. European Archives of Psychiatry and Clinical Neuroscience, 254(4), 256-262.
17. Cohen, A. S., Forbes, C. B., Mann, M. C., & Blanchard, J. J. (2006). Specific cognitive deficits and differential domains of social functioning impairment in schizophrenia. Schizophrenia Research, 81(2-3), 227-238.
18. Cook, A. M., & Polgar, J. M. (2008). Cook & Hussey's assistive technologies: principles and practive, third edition. St Louis: Mosby Elsevier.
19. Corbière, M. (2008). Work integration of people with schizophrenia and other severe mental disorders. Revue Québécoise de Psychologie, 29(1), 95-110.
20. Cuffel, B. J., Alford, J., Fischer, E. P., & Owen, R. R. (1996). Awareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis, 184(11), 653-659.
21. Davies, D. K., Stock, S. E., & Wehmeyer, M. L. (2002). Enhancing independent time-management skills of individuals with mental retardation using a Palmtop personal computer. Mental Retard, 40(5), 358-365.
22. Dawe, M. (2007). Reflective Design-in-Use: Co-Designing an Assitive Remote Communication System with Individuals with Cognitive Disabilities and Their Families. Unpublished Ph.D. proposal, University of Colorado.
23. Demily, C., & Franck, N. (2008). Cognitive remediation: a promising tool for the treatment of schizophrenia. Expert Rev Neurother, 8(7), 1029-1036.
24. Depompei, R., Gillette, Y., Goetz, E., Xenopoulos-Oddsson, A., Bryen, D., & Dowds, M. (2008). Practical applications for use of PDAs and smartphones with children and adolescents who have traumatic brain injury. NeuroRehabilitation, 23(6), 487-499.
25. Fisher, G., Giaccardi, E., Ye, Y., Sutcliffe, A., & Mehandjiev, N. (2004). Meta-design: a manifesto for end-user development. Paper presented at the Communications of the ACM.
26. Fisher, G., McCall, R., Ostwald, J., Reeves, B., & Shipman, F. (1994). Seeding, Evolutionary growth and Reseeding: suporting the incremental development of design environments. Paper presented at the Human factors in computing systems. Proceedings of the SIGCHI conference of human factors in computing systems: celebrating interindependance., Boston, Massachusetts, US.
27. Fisher, G., & Ostwald, J. (2002). Seeding, Evolutionary growth and Reseeding: enriching articipatory design with informed participation. Paper presented at the Proceedings of the participatory design conference (PDC'02), Malmö, Sweden.
28. Franck, N. (2006). La schizophrénie: la reconnaître et la soigner. Paris: Odile Jacob.
29. Freudenreich, O., & Tranulis, C. (2009). A prototype approach toward antipsychotic medication adherence in schizophrenia. Harv Rev Psychiatry, 17(1), 35-40.
30. Gelinas, D. (1998 ). Points de repères pour différencier la gestion de cas du suivi intensif dans le milieu auprès des personnes souffrant de troubles mentaux graves. Santé Mentale au Québec, 23, 17-47.
31. Giraud-Baro, E., Vidon, G., & Leguay, D. (2006). Soigner, réhabiliter : pour une reformulation de l’offre de soins et de services. L’Information psychiatrique, 82, 281-286.
32. Goldman-Rakic, P. S. (1991). Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory (Carrol, B. & Barrett, J.E. ed.). New York City: Raven Press.
33. Granholm, E., Loh, C., & Swendsen, J. (2009). Feasability and validity of Computerised ecological Momentary Assessment in schizophrenia. Schizophrenia Bulletin, 34(3), 507-514.
34. Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153(3), 321-330.
35. Green, M. F., Kern, R. S., & Heaton, R. K. (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research, 72(1), 41-51.
36. Hofer, A., Baumgartner, S., Bodner, T., Edlinger, M., Hummer, M., Kemmler, G., et al. (2005). Patient outcomes in schizophrenia II: the impact of cognition. European Psychiatry, 20(5-6), 395-402.
37. Horne, R., & Weinman, J. (1999). Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res, 47(6), 555-567.
38. Jeste, S. D., Patterson, T. L., Palmer, B. W., Dolder, C. R., Goldman, S., & Jeste, D. V. (2003). Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res, 63(1-2), 49-58.
39. Johnson, E. I., Grondin, O., Barrault, M., Faytout, M., Helbig, S., Husky, M., et al. (2009). Computerized ambulatory monitoring in psychiatry: a multi-site collaborative study of acceptability, compliance, and reactivity. Int J Methods Psychiatr Res, 18(1), 48-57.
40. Kampman, O., & Lehtinen, K. (1999). Compliance in psychoses. Acta Psychiatr Scand, 100(3), 167-175.
41. Kay, R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
42. Keefe, R. S., Bilder, R. M., Davis, S. M., Harvey, P. D., Palmer, B. W., Gold, J. M., et al. (2007). Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry, 64(6), 633-647.
43. Kirsch, N., Levine, S., Lajiness, R., Mossaro, M., Schneider, M., & Donders, J. (1988). Improving functional performance with computerized task guidance systems. ICAART'88 Annual Conference.
44. Koechlin, E., Ody, C., & Kouneiher, F. (2003). The architecture of cognitive control in the human prefrontal cortex. Science, 302(5648), 1181-1185.
45. Konig, H. H., Roick, C., & Angermeyer, M. C. (2007). Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. Eur Psychiatry, 22(3), 177-187.
46. Kurtz, M. M., & Wexler, B. E. (2006). Differences in performance and learning proficiency on the Wisconsin Card Sorting Test in schizophrenia: do they reflect distinct neurocognitive subtypes with distinct functional profiles? Schizophrenia Research, 81(2-3), 167-171.
47. Lacro, J. P., Dunn, L. B., Dolder, C. R., Leckband, S. G., & Jeste, D. V. (2002). Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry, 63(10), 892-909.
48. Laes, J. R., & Sponheim, S. R. (2006). Does cognition predict community function only in schizophrenia?: a study of schizophrenia patients, bipolar affective disorder patients, and community control subjects. Schizophrenia Research, 84(1), 121-131.
49. Lazarus, R. S., & Folkam, S. (1984). Stress, appraisal and coping. New York City: Springer.
50. Le Gall, D., & Peigneux, P. (2004). Les apraxies: Formes cliniques et modèles théoriques. (D. Le Gall & G. Aubin ed.). Marseille: Solal.
51. Lecomte, T., Wallace, C. J., Caron, J., Perreault, M., & Lecomte, J. (2004). Further validation of the Client Assessment of Strengths Interests and Goals. Schizophr Res, 66(1), 59-70.
52. LoPresti, E., Mihailidis, A., & Kirsch, N. (2004). Assistive technology for cognitive rehabilitation : State of the art. Neuropsychological Rehabilitation, 14(1/2), 5-39.
53. Marder, S. R. (2006). The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia. Dialogues Clin Neurosci, 8(1), 109-113.
54. McGurk, S. R., & Mueser, K. T. (2004). Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model. Schizophrenia Research, 70(2-3), 147-173.
55. McGurk, S. R., Mueser, K. T., Feldman, K., Wolfe, R., & Pascaris, A. (2007). Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial. American Journal of Psychiatry, 164(3), 437-441.
56. Mohr, D. C., Goodkin, D. E., Likosky, W., Gatto, N., Neilley, L. K., Griffin, C., et al. (1996). Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment. Mult Scler, 2(5), 222-226.
57. Nguyen, M. R. (2010). Smart pill dispenser. Retrieved July 23, 2010, from http://www.freepatentsonline.com/y2010/0076595.html
58. Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004). Identification of separable cognitive factors in schizophrenia. Schizophrenia Research, 72(1), 29-39.
59. O'Brien, M. K., Petrie, K., & Raeburn, J. (1992). Adherence to medication regimens: updating a complex medical issue. Med Care Rev, 49(4), 435-454.
60. Patterson, T. L., Goldman, S., McKibbin, C. L., Hughs, T., & Jeste, D. V. (2001). UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophrenia Bulletin, 27(2), 235-245.
61. Perkins, D. O. (2002). Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry, 63(12), 1121-1128.
62. Perkins, D. O., Gu, H., Weiden, P. J., McEvoy, J. P., Hamer, R. M., & Lieberman, J. A. (2008). Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry, 69(1), 106-113.
63. Perry, W., Heaton, R. K., Potterat, E., Roebuck, T., Minassian, A., & Braff, D. L. (2001). Working memory in schizophrenia: transient "online" storage versus executive functioning. Schizophr Bull, 27(1), 157-176.
64. Petrides, M. (1995). Impairments on nonspatial self-ordered and externally ordered working memory tasks after lesions of the mid-dorsal part of the lateral frontal cortex in the monkey. J Neurosci, 15(1 Pt 1), 359-375.
65. Peuskens, J., Demily, C., & Thibaut, F. (2005). Treatment of cognitive dysfunction in schizophrenia. Clinical Therapeutics, 27 Suppl A, S25-37.
66. Prouteau, A., Verdoux, H., Briand, C., Lesage, A., Lalonde, P., Nicole, L., et al. (2005). Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophrenia Research, 77(2-3), 343-353.
67. Revheim, N., Schechter, I., Kim, D., Silipo, G., Allingham, B., Butler, P., et al. (2006). Neurocognitive and symptom correlates of daily problem-solving skills in schizophrenia. Schizophrenia Research, 83(2-3), 237-245.
68. Rialle, V. (2007). Technologie et Alzheimer. Unpublished Ph.D. Thesis, University of Paris 5, Paris.
69. Robinson, D. G., Woerner, M. G., Alvir, J. M., Bilder, R. M., Hinrichsen, G. A., & Lieberman, J. A. (2002). Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr Res, 57(2-3), 209-219.
70. Rogers, E. M. (1995). Diffusion of innovations, Fourth edition. New York City: Free Press.
71. Savard, L., Borstad, A., Tkachuck, J., Lauderdale, D., & Conroy, B. (2003). Telerehabilitation consultations for clients with neurologic diagnoses: cases from rural Minnesota and American Samoa. NeuroRehabilitation, 18(2), 93-102.
72. Schwartz, M. F. (2006). The cognitive neuropsychology of everyday action and planning. Cognitive Neuropsychology, 23(1), 202-221.
73. Schwartz, M. F. (2006). The cognitive neuropsychology of everyday action and planning. Cognitive Neuropsychology, 23(1), 202-221.
74. Seron, X., Van Der Linden, M., & Andrés, P. (1999). Le lobe frontal : à la recherche de ses spécifictés fonctionnelles. In M. V. D. Linden, X. Seron, D. L. Gall & P. Andrés (Eds.), Neuropsychologie des lobes frontaux (pp. 33-88). Marseille: Solal.
75. Shallice, T., Burgess, P. W., Schon, F., & Baxter, D. M. (1989). The origins of utilization behaviour. Brain, 112 ( Pt 6), 1587-1598.
76. Sharma, T., & Antonova, L. (2003). Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatric Clinics of North America, 26(1), 25-40.
77. Silverstein, S. M., & Wilkniss, S. M. (2004). At issue: The future of cognitive rehabilitation of schizophrenia. Schizophrenia Bulletin, 30(4), 679-292.
78. Sirigu, A., Zalla, T., Pillon, B., Grafman, J., Agid, Y., & Dubois, B. (1996). Encoding of sequence and boundaries of scripts following prefrontal lesions. Cortex, 32(2), 297-310.
79. Stip, E., Chouinard, S., & Boulay, L. J. (2005). On the trail of a cognitive enhancer for the treatment of schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 29(2), 219-232.
80. Velligan, D. I., Bow-Thomas, C. C., Huntzinger, C., Ritch, J., Ledbetter, N., Prihoda, T. J., et al. (2000). Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia. American Journal of Psychiatry, 157(8), 1317-1323.
81. Velligan, D. I., Bow-Thomas, C. C., Mahurin, R. K., Miller, A. L., & Halgunseth, L. C. (2000). Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Journal of Nervous and Mental Disease, 188(8), 518-524.
82. Velligan, D. I., Kern, R. S., & Gold, J. M. (2006). Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophrenia Bulletin, 32(3), 474-485.
83. Velligan, D. I., Lam, Y. W., Glahn, D. C., Barrett, J. A., Maples, N. J., Ereshefsky, L., et al. (2006). Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull, 32(4), 724-742.
84. Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., et al. (2010). Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the Expert Consensus Guidelines. J Psychiatr Pract, 16(1), 34-45.
85. Weiden, P. J. (2007). Understanding and addressing adherence issues in schizophrenia: from theory to practice. J Clin Psychiatry, 68 Suppl 14, 14-19.
86. Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004). Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv, 55(8), 886-891.
87. Wilson, B. A., Emslie, H. C., Quirk, K., & Evans, J. J. (2001). Reducing everyday memory and planning problems by means of a paging system: a randomised control crossover study. Journal of Neurology, Neurosurgery and Psychiatry, 70(4), 477-482.
88. Wilson, B. A., Evans, J. J., Emslie, H., & Malinek, V. (1997). Evaluation of NeuroPage: a new memory aid. Journal of Neurology, Neurosurgery and Psychiatry, 63(1), 113-115.
89. Wu, J. Y., Leung, W. Y., Chang, S., Lee, B., Zee, B., Tong, P. C., et al. (2006). Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ, 333(7567), 522.
90. Zalla, T., Posada, A., Georgieff, N., & Sirigu, A. (2001). A component analysis of action planing in schizophrenia. A comparison with patient with frontal lobe damage. Cognitive Neuropsychiatry, 6(4), 271-296.
91. Zanetti, O., Zanieri, G., Vreese, L., Frisoni, G., & Binetti, G. (2000). Utilizing an electronic memory aid with Alzheimer's disease patients. A study of feasability. Paper presented at the Sixth International Stockholm/Springfield Symposieum on Advances in Alzheimer Therapy, Stockholm.
92. Zygmunt, A., Olfson, M., Boyer, C. A., & Mechanic, D. (2002). Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry, 159(10), 1653-1664.